Virtual
Past Meetings
648 meetings available
Switzerland
Virtual: 7th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology
- CME:
- 25 Cat.1 ESMO MORA points
- Languages:
- English
Virtual, Switzerland
ESMO in Focus LatAm 2021
- Languages:
- English
- Portuguese
- Spanish
ESMO Virtual Plenary: October 2021
Virtual and in Cluj-Napoca, Romania
Annual Congress of the Romanian Society for Radiotherapy and Medical Oncology
- CME:
- 25 cat. 1 ESMO MORA points
- Languages:
- English
- Romanian
Šibenik, Croatia
13th Congress of the Croatian Society of Medical Oncology (HDIO)
- CME:
- TBC
- Languages:
- Croatian
Virtual, CEST Time
ESMO Virtual Advanced Course on KRAS Targeting in NSCLC 2021
Brno, Czech Republic
45th Brno Oncology Days Meeting
- CME:
- 20 Cat. 1
- Languages:
- English
- Czech
- Slovak
Virtual Meeting
The Clinical Trials Regulation and Its Impact on Oncology
Virtual
Virtual and in Berlin, Germany
Annual Meeting of the German, Austrian and Swiss Associations for Haematology and Medical Oncology
- CME:
- 25 cat.1 ESMO MORA points
- Languages:
- German
ESMO Guidelines: Real World Cases - Webinar Series: Small Cell Lung Cancer
Virtual, CEST Time
ESMO Virtual Advanced Course on Clinical Questions in Prostate Cancer 2021: September
Virtual, GMT +8
ESMO Virtual Preceptorship on Head and Neck Cancer 2021
Virtual, CEST Time
ESMO Virtual Preceptorship on Breast Cancer 2021: September
Zurich, Switzerland
ESMO in the Alps 2021
- Languages:
- English
Germany
ESMO Today 2021
- Languages:
- German
ESMO Congress 2021
Virtual, GMT +8
ESMO Virtual Advanced Course on Biomarkers for Precision Medicine 2021
Virtual, CEST Time
ESMO Virtual Preceptorship on Ovarian Cancer 2021
Seoul, Korea, Republic of
KSMO 2021 Congress - Joint Session with ESMO
Virtual, CEST Time
ESMO Virtual Preceptorship on Cancer Care in Elderly Patients 2021
ESMO Academy Virtual Meeting 2021
Virtual, CEST Time
ESMO-EANM Virtual Advanced Course on Diagnostic and Therapeutic Applications of Nuclear Medicine in Oncology 2021
KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab + chemotherapy vs. placebo + chemotherapy, followed by adjuvant pembrolizumab vs. placebo for early-stage TNBC
Switzerland
Virtual: ESO-ESMO Baltic and Eurasia Masterclass in Clinical Oncology
- CME:
- 25 Cat.1 ESMO-MORA points
- Languages:
- English
Virtual Meeting